Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Historical Growth of the Adult Vaccines Market: Insights into Expanding Industry Size
In recent times, the market size for adult vaccines has seen significant growth. The market is projected to expand from a size of $22.82 billion in 2024 to $24.21 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.1%. Several factors have contributed to this development in the historic period including an increased aging population, government-backed vaccination initiatives, a rise in the awareness of preventive healthcare measures, vaccine research and innovation, as well as public health campaigns.
Anticipated to experience robust growth in the coming years, the adult vaccines market is projected to escalate to $34.19 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. This growth during the forecasted period could be ascribed to the emergence of new infectious diseases, enhanced emphasis on immunization registries, threat of increasing antimicrobial resistance, worldwide initiatives for pandemic readiness, transition towards personalized vaccines, and a heightened focus on maternal immunization. Major trends forecasted to arise during this period encompass integration of digital health, progression in vaccine production technology, partnerships amongst governments and pharmaceutical firms, advancements in vaccine delivery technology, and the expansion of immunization programs.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Primary Drivers Are Boosting the Adult Vaccines Market’s Performance?
The escalating incidence of infectious diseases is propelling the growth of the adult vaccine market. Infectious diseases are those that can be transmitted from one individual to another. Vaccinations serve as a potent tool in combating these infections by aiding individuals in building immunity against them. To illustrate, the Centers for Disease Control and Prevention, a national public health institution in the US, reported that the number of tuberculosis cases in 2022 rose to 8,300 from 7,874 in 2021. Furthermore, the rate of TB incidence per 100,000 individuals also increased marginally to 2.5 in 2022, compared to 2.4 the previous year. Hence, the escalating incidence of infectious diseases acts as a catalyst for the expansion of the adult vaccine market.
Which Key Segments Are Driving Growth in the Adult Vaccines Market?
The adult vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the Key Trends Forecasted to Reshape the Adult Vaccines Industry Structure?
One significant trend that’s being observed in the adult vaccines market is the emphasis on product innovations.
In a bid to maintain their dominance in the market, prominent companies are focusing on launching creative products. For instance, GSK, a biopharma company from the UK, and IQVIA, a firm from India offering superior analytics, technology solutions, and clinical research services, released Vaccine Track. This initiative was announced in August 2022 as a platform to track data trends and boost adult immunization on a national scale. The platform regularly provides critical data trends to bolster public health initiatives.
Which Geographies Are Leading the Expansion of the Adult Vaccines Market?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Adult Vaccines Market in 2025?
Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=9038
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
